3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
camrelizumab
×
1 year
×
Clear all
No trials found.